 s resolved annually by the annual general meeting and disclosed in note 5 on page 59 in the annual report 2024. Key developments 2024 The CEO summarizes the company’s overall performance in his statement on pages 3-4 in the annual report 2024. The company’s remuneration guidelines: scope, purpose and deviations A prerequisite for the successful implementation of the company’s business strategy and safeguarding of its long-term interests, including its sustainability, is that the company can recruit and retain qualified personnel. To this end, the company must offer competitive remuneration. The company’s remuneration guidelines enable the company to offer executives a competitive total remuneration. Under the remuneration guidelines, executive remuneration shall be on market terms and may consist of the following components: fixed cash salary, variable cash remuneration, pension benefits and other benefits. The variable cash remuneration shall be linked to financial or non- financial c  or non- financial criteria. They may be individualized, quantitative or qualitative objectives. The criteria shall be designed to contribute to the company’s business strategy and long-term interests, by for example being clearly linked to the business strategy or promote the executive’s long-term development. The guidelines are found on page 57-58 in the annual report 2024. The remuneration guidelines have been fully implemented. No deviations from the guidelines have been decided and no derogations from the procedure for implementation of the guidelines have been made. The auditor’s report regarding the company’s compliance with the guidelines is available www.karolinskadevelopment.com/en/corporate-governance. No remuneration has been reclaimed.

Table 1 – Total CEO and Deputy CEO renumeration 2024 (kSEK) 6 Fixed remuneration Variable remuneration Name of director (position) Base salary1 Other benefits2 Short-term incentive program 20233 Extraordinary remuneration4 Pension expense T n4 Pension expense Total remuneration Proportion of fixed and variable remuneration5 Viktor Drvota 3 062 15 310 443 992 4 821 85/15 (CEO) Johan Dighed 1 877 3 184 309 458 2 830 83/17 (Deputy CEO) 1 Including holiday pay: Viktor Drvota 54 kSEK, Johan Dighed 33 kSEK. 2 Refers to benefit value of health insurance. 3 Details, see table 2 below and Annual Report Note 5, page 59. 4 Refers to Exit bonus. Details, see Annual Report Note 5, page 59. 5 Pension expense, which in its entirety relates to Base salary and is premium defined, has been counted entirely as fixed remuneration. 6 Total CEO and Deputy CEO remuneration is in compliance with the company’s guidelines on remuneration. Share-based remuneration Outstanding share-related and share price-related incentive plans There are no share-related or share price-related incentive programs in the company. Application of performance criteria The performance measures for the CEO and the Deputy CEO’s variable remuneration have been selected to  ve been selected to deliver the company’s strategy and to encourage behavior which is in the long-term interest of the company. In the selection of performance measures, the strategic objectives and short-term and long-term business priorities for 2024 have been taken into account. The non-financial performance measures further contribute to alignment with sustainability as well as the company values. Table 2 – Description of the outcome of the variable short-term compensation Name of director (position) Description of the criteria related to the remuneration component Relative weighting of the performance criteria a) Measured performance and b) Actual award/ remuneration outcome (SEK) Portfolio Management 40% a) 0% (Umecrine Cognition) b) 0 Viktor Drvota Portfolio Management 40% a) 0% (CEO) (Dilafor) b) 0 Portfolio Management 20% a) 20% (Other Companies) b) 310 000

Name of director (position) Description of the criteria related to the remuneration component Relative weighting of the  ve weighting of the performance criteria a) Measured performance and b) Actual award/ remuneration outcome (SEK) Portfolio Management 40% a) 0% (Umecrine Cognition) b) 0 Johan Dighed Portfolio Management 40% a) 0% (Deputy CEO) (Dilafor) b) 0 Portfolio Management 20% a) 20% (Other Companies) b) 184 000 Table 3 – Change of remuneration and company performance over the last five reported financial years (RFY) (kSEK) RFY-4 vs RFY-5 RFY-3 vs RFY-4 RFY-2 vs RFY-3 RFY-1 vs RFY-2 RFY vs RFY-1 RFY 2023 CEO remuneration -602 -11.1% -451 -9.1% 614 11.0% -830 -17.5% 88 1.8% 4 821 Deputy CEO remuneration -845 -24.2% -541 -18.4% 271 8.4% -474 -17.3% 86 3.0% 2 830 Balance sheet: Portfolio companies at fair value through profit/loss -277 280 -36.0% 179 850 -18.9% 33 825 3.4% 116 403 10.6% 20 379 1.8% 1 120 777 Income statement: Change in fair value of shares in portfolio companies -630 514 -292.7% 438 581 196.5% -299 286 393.4% 91 268 601.0% -13 601 861.7% 1 579 Average remuneration on a full-time equ